We believe that everyone deserves a good life, and for some that is only possible when the medicine is just right.
Therefore we are writing a new chapter in personalized medicine. OnDosis Dosage Manager delivers flexible and individualized dosing of oral medicines formulated as pellets, granules, mini tablets or powders. OnDosis is currently developing products for individualized dosing to help 100's of thousands of patients diseases with a significant unmet needs such as ADHD, food allergies, pain and immunosuppression for organ transplants.
OnDosis was founded as a spin-out from AstraZeneca in 2017 and is headquartered at GoCo House in Gothenburg, Sweden.
Company Details
- Employees
- 38
- Founded
- -
- Address
- Gemenskapens Gata 9, Goco House,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- ondosis.com
- Keywords
- Intelligent dosing, Individulised, Device, Health tech, Pharmaceuticals, Med tech, ADHD, Pain, Immunosuppression, Pediatrics, Digital, Connected, Formulation, precision medicine.
- HQ
- Gothenburg, Västra Götaland County
Ondosis Questions
Ondosis's website is ondosis.com
Ondosis's LinkedIn profile is https://se.linkedin.com/company/ondosis
Ondosis has
38 employees.
View email and phone details for 38
employees at Ondosis.
Ondosis's industry is
Pharmaceutical Manufacturing
Ondosis's top competitors are
Simsen Diagnostics,
Tiefenbacher Group,
Integrum Ab,
Nextera As,
Thermo Fisher Scientific,
Amferia Kills Bacteria,
Clexbio,
Circio Holding Asa,
Xvivo,
Star.
Ondosis's categories are Pharmaceutical Manufacturing
Ondosis's founding year is 2017
